Asthma and Allergic Diseases Cooperative Research Centers
The summary for the Asthma and Allergic Diseases Cooperative Research Centers grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Asthma and Allergic Diseases Cooperative Research Centers: - The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from single institutions and consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The purpose of this RFA is to support basic and clinical research on the immunological basis, pathobiology, diagnosis, treatment and prevention of asthma and allergic diseases and to accelerate the application of fundamental knowledge of immune function to the investigation, prevention, and treatment of asthma and allergic diseases. - In FY 2006, NIAID anticipates awarding a total of $11 million to support the Centers. Additional discretionary funds of $1 million per year will be provided to support new projects on emerging opportunities. - Seven to ten new awards are anticipated. - This initiative will be funded using the multi-project Cooperative Agreement (U19) award mechanism. - A minimum of two research projects must be proposed. At least one of the projects must focus on immunologic aspects of asthma and/or allergic diseases in humans, and must be qualified as clinical research as defined in NIH grant guidance and policy (http://grants.nih.gov/grants/policy/hs/index.htm). - An institution may submit only one application; however, applications may include investigators from more than one institution if such arrangements enhance the scientific strength of the proposed research program. In addition, a Principal Investigator may serve as a Project Leader in a multi-project application if there is no scientific overlap with the application submitted by the Principal Investigator. - Eligible organizations include: domestic for-profit and non-profit organizations; public and private institutions, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with a domestic institution serving as the primary applicant. - Eligible Principal Investigators include all individuals with the skills, knowledge, and resources necessary to carry out the proposed research. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. - The PHS 398 document is available at http://grants.nih.gov/grants/funding/phs398/phs398.html. For further assistance contact Grantsinfo, Telephone (301)435-0714, Email: Grantsinfo@nih.gov. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
|Federal Grant Title:||Asthma and Allergic Diseases Cooperative Research Centers|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-AI-05-027|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Allergy, Immunology and Transplantation Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Oct 12, 2005|
|Posted Date:||May 25, 2005|
|Creation Date:||May 25, 2005|
|Archive Date:||Nov 11, 2005|
|Total Program Funding:||$11,000,000|
|Maximum Federal Grant Award:||$1,000,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:||7|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with the domestic institution as the primary applicant.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Cellular Therapies for Treatment of Radiation Injuries (U01)
- • International Research in Infectious Diseases, including AIDS (R01)
- • NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
- • Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R0...
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)